Etoposide (VP 16-213) Induced Hepatitis. Report of Three Cases Following Standard-dose Treatments
Overview
Authors
Affiliations
Acute hepatitis is a potential, although rare, complication following administration of high doses of Etoposide (VP 16-213). We report three cases of severe hepatocellular necrosis following administration of standard doses of this antineoplastic agent.
Successful management of a rare case of gallbladder neuroendocrine carcinoma with tumor thrombi.
Pal B, Dutta S, Naik D, Sudharsanan S, Ganesh R, Nelamangala Ramakrishnaiah V Int Cancer Conf J. 2023; 12(4):248-254.
PMID: 37577342 PMC: 10421793. DOI: 10.1007/s13691-023-00617-7.
Mohammed A, Al-Hassani A, Alrawi R, Tawfeeq R Ecancermedicalscience. 2023; 17:1499.
PMID: 36816786 PMC: 9937074. DOI: 10.3332/ecancer.2023.1499.
McKeone D, DeMartini T, Kavanagh R, Halstead E Front Pediatr. 2021; 9:681055.
PMID: 34277520 PMC: 8282902. DOI: 10.3389/fped.2021.681055.
Biological alterations in renal and hepatic tissues by a novel gold (III) anti-cancerous compound.
Ahmed A, Alkhawajah A, Al-Tamimi D, Shawarby M, Isab A, Badar A Iran J Basic Med Sci. 2018; 21(10):1064-1072.
PMID: 30524681 PMC: 6281062. DOI: 10.22038/IJBMS.2018.28622.6935.
Hepatotoxicity Secondary to Chemotherapy.
Grigorian A, OBrien C J Clin Transl Hepatol. 2015; 2(2):95-102.
PMID: 26357620 PMC: 4521265. DOI: 10.14218/JCTH.2014.00011.